Rhode Islanders insured under UnitedHealthcare’s Medicare Advantage plans may once again have to find new doctors amid ...
Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results